ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban
Hamin Kim,1,* Tae-Jin Song,2,* Jeong Yee,1 Dong-Hyeok Kim,3 Junbeom Park,4 Hye Sun Gwak1 1College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea; 2Department of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, Se...
Enregistré dans:
Auteurs principaux: | Kim H (Auteur), Song TJ (Auteur), Yee J (Auteur), Kim DH (Auteur), Park J (Auteur), Gwak HS (Auteur) |
---|---|
Format: | Livre |
Publié: |
Dove Medical Press,
2023-08-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban
par: Frost C, et autres
Publié: (2014) -
A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]
par: Frost C, et autres
Publié: (2018) -
Gene Polymorphisms of the Renin-Angiotensin System and Bleeding Complications of Warfarin: Genetic-Based Machine Learning Models
par: Joo-Hee Kim, et autres
Publié: (2021) -
Effects of Polymorphisms in Myc-Related Genes on Bleeding Complications in Patients with Stable Warfarin Responses
par: Jeong Yee, et autres
Publié: (2019) -
ABCG2 Single Nucleotide Polymorphism Affects Imatinib Pharmacokinetics in Lower Alpha-1-Acid Glycoprotein Levels in Humans
par: Jin-Woo Park, et autres
Publié: (2021)